The Microcap Kitchen: Stocks 5¢ to $5 | Stock Discussion Forums

SiliconInvestor

register

Sponsor

register

Microcap & Penny Stocks | The Microcap Kitchen: Stocks 5¢ to $5

Previous 10 | Next 10

To: Jeffrey Beckman who wrote (106182)	12/20/2011 3:03:45 AM
From: Todmohr	of 111090

BFDI..Jeff..Thanks for that very detailed list and breakdown - it was very informative. I do understand their lack of popularity. I guess my point was that there is plenty of room for growth in BFDI - based on the amount of states that do permit one or both of the technologies, as well as the many states where no current law exists. If BFDI manages to win business in even a couple of more states, their revenues and earnings will grow significantly... Until they do make that breakthrough into other states, your concern is a very legitimate one. That said, with all the states out there with no programs, I believe that breakthrough is coming. Regards, Tod

Share	Recommend \| Keep \| Reply \| Mark as Last Read

From: benignFeO2	12/20/2011 9:46:10 AM
	2 Recommendations of 111090

IMSC .62 +.02 Implant Sciences' Quantum Sniffer QS-B220 Receives Confirmation of Eligibility for TSA Air Cargo Screening Qualification Testing Notification Marks Significant Milestone Towards Full TSA Qualification of Benchtop Explosives Trace Detector WILMINGTON, MA--(Marketwire -12/20/11)- Implant Sciences Corporation (OTCQB: IMSC.PK - News) (Pinksheets: IMSC.PK - News), a high technology supplier of systems and sensors for homeland security markets, today announced it has received notification of vendor eligibility in the Air Cargo Screening Qualification Test Qualification Group 2 from the U.S. Transportation Security Administration (TSA) for its Quantum Sniffer™ QS-B220 benchtop explosives trace detector. TSA qualification is required before any explosives detection device can be commercially sold for use in air cargo screening facilities shipping to or from U.S. airports. In order to receive vendor eligibility status, Implant Sciences submitted a comprehensive Qualification Data Package (QDP) detailing the QS-B220's performance metrics to TSA. Preparation of the QDP included collecting and analyzing thousands of samples in real-world environments, including active certified cargo screening facilities. Future steps in completing the Air Cargo Screening Qualification Testing will involve TSA confirming the QS-B220's operating performance to prove the system meets their specifications. "Notification of eligibility is a significant milestone for Implant Sciences. While this does not imply qualification of the QS-B220, we are confident that our system will perform to TSA's requirements and successfully complete the qualification process," stated Glenn D. Bolduc, President and CEO of Implant Sciences. About the Quantum Sniffer™ QS-H150 The QS-H150 is a handheld explosives trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. The QS-H150 uses no radioactive materials and features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability. About the Quantum Sniffer™ QS-B220 The QS-B220, introduced in May 2011, is a benchtop explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives, plus narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability. About Implant Sciences Implant Sciences develops, manufactures, and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed innovative proprietary technologies used in its explosives and narcotics trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences products have been deployed in a wide range of security environments including airports, subways, railways, cargo facilities, nuclear power plants, police departments, military units, government buildings, and financial institutions. The QS-H150 and QS-B220 are Department of Homeland Security (DHS) Qualified Anti-Terrorism Technologies under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com. Safe Harbor Statement This press release may contain certain "forward-looking statements

Share	Recommend \| Keep \| Reply \| Mark as Last Read

To: zen_lunatic420 who wrote (105944)	12/20/2011 11:26:11 AM
From: zen_lunatic420	of 111090

RX.v (BOIYF.pk): I see the latest news didn't get posted last week, so I decided to post it now. This new director with many connections in the Canadian pharmaceutical business looks like a good addition to the BOD, who might be able to help them bring in some new product licensing agreements....and provide some guidance for building their sales and marketing organization as well: BioSyent Announces Appointment of New DirectorPress Release: BioSyent Inc. – Thu, Dec 15, 2011 5:48 PM EST MISSISSAUGA, ONTARIO--(Marketwire -12/15/11)- The Board of Directors of BioSyent Inc. ("BioSyent") (TSX-V: RX.V - News) is pleased to announce the appointment of Paul R. Montador to the Company's Board. Mr. Montador brings to BioSyent Inc. over 35 years of experience in healthcare product sales, marketing, leadership and corporate governance. At present, he is the CEO (founder) of InspiAir Inc. and Chairman of the Board of ThinkFirst/Pensez d'Abord Canada, a national non-profit organization dedicated to the prevention of brain and spinal cord injuries. Over the last 20 years Mr. Montador's roles have also included CEO of SciCan Inc., President of Johnson & Johnson Medical Products (Canada), President and Board member of Amsco Inc. (acquired by Steris Corporation), Vice-President and General Manager of American Hospital Supply (Canada) (acquired by Baxter Corp.) and Board member of CryoCath Technologies Inc. (acquired by Medtronic, Inc.). BioSyent Inc. also announces the grant of 25,000 incentive stock options to a Director of the Company. These incentive stock options are exercisable at a price of $0.50 up to December 15, 2016. BioSyent Inc. continues to concentrate on its pharmaceutical strategy to source products that have been successfully developed and proven to be safe and effective; manage these products through the regulatory process and product registration (approval); and once approved, market these products in Canada. The Company is focused on medications that occupy a niche in the market, that are unique either due to complexity of manufacture or provide novel technological or therapeutic advantages, or that are backed by strong partners holding intellectual property rights that are defendable. This strategy allows the Company to market these medications as brands owned by, or licensed to, it. BioSyent Inc. is a publicly traded specialty pharmaceutical company whose wholly owned subsidiary, BioSyent Pharma Inc., sources, acquires or in-licences pharmaceutical products and markets these products in Canada. Wholly owned BioSyent subsidiary Hedley Technologies Ltd. operates the company's legacy business marketing bio and health friendly non-chemical insecticides. BioSyent common shares are listed for trading on the TSX Venture Exchange (TSXV) under the symbol RX. This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be materially different from the forward-looking information or statements. Potential risks may include, but are not limited to, those associated with clinical trials, product development, future revenue, operations, profitability and obtaining regulatory approvals. The TSX Venture Exchange assumes no responsibility for the accuracy of this release and neither approves nor disapproves of the same. Contact: BioSyent Inc. Rene C. Goehrum President and CEO www.biosyent.com

Share	Recommend \| Keep \| Reply \| Mark as Last Read \| Read Replies (1)

To: ksuave who wrote (106189)	12/20/2011 2:02:41 PM
From: caly	1 Recommendation of 111090

I got the postcard in the mail yesterday too. I owned AXGI in this list. AGWS AXGI BFRE DSEN ILKG MLTO NASV PKGH PECD RSUV RVDO STRU THE TARGETED ISSUERS 17. Advanced Growing Systems, Inc. (“Advanced Growing”) is a Nevada corporation with its principal place of business in Alpharetta, Georgia. Its securities are registered with the Commission under Section 12(g) of the Exchange Act [15 U.S.C. § 78l(g)]. Advanced Growing purports to manufacture and sell organic fertilizer. Advanced Growing’s securities are dually quoted on the OTC Bulletin Board and the Pink Sheets under the symbol “AGWS.” 18. Axium Technologies, Inc. (“Axium”) is a Delaware corporation with its principal place of business in Pasadena, California. Axium purports to be a provider of digital security systems. Axium’s securities are quoted on the Pink Sheets under the symbol “AXGI.” 19. Bluefire Ethanol Fuels, Inc. (“Bluefire”) is a Nevada corporation with its principal place of business in Irvine, California. Its securities are registered with the Commission under Section 12(g) of the Exchange Act [15 U.S.C. § 78l(g)]. Bluefire purports 5 Case 3:10-cv-01068-O Document 1 Filed 05/27/10 Page 6 of 36 PageID 6 to be a provider of technology for the conversion of bio-waste to ethanol. Bluefire’s securities are dually quoted on the OTC Bulletin Board and the Pink Sheets under the symbol “BFRE.” 20. Datascension, Inc. (“Datascension”) is a California corporation with is principal place of business in Brea, California. Its securities are registered with the Commission under Section 12(g) of the Exchange Act [15 U.S.C. § 78l(g)]. Datascension purports to be a data gathering and research company in the U.S., Costa Rica, and the Dominican Republic. Datascension’s securities are dually quoted on the OTC Bulletin Board and the Pink Sheets under the symbol “DSEN.” 21. Interlink Global Corp. (“Interlink”) is a Florida corporation with its principal place of business in Miami, Florida. Interlink purports to be a provider of telecommunications and internet services. Interlink’s stock is quoted on the Pink Sheets using the symbol “ILKG.” 22. Medirect Latino, Inc. (“Medirct Latino”) was incorporated in Florida but was foreclosed upon by its lenders. Its principal place of business was in Ft. Lauderdale, Florida. Its securities were formerly registered with the Commission under Section 12(g) of the Exchange Act [15 U.S.C. § 78l(g)] until the company voluntarily terminated its registration in September 2007. Medirect Latino purported to supply diabetic medical supplies to the Latino community. It formerly was quoted on the Pink Sheets under the symbol “MLTO.” 23. National Automation Services, Inc. (“NASV”) is a Nevada corporation with its principal place of business in Henderson, Nevada. NASV purports to be run a network of automation and controls companies throughout the nation. Its stock is quoted on the Pink Sheets under the symbol “NASV.” 24. Packaged Home Solutions, Inc. (“Packaged Home”) was a Florida corporation that abandoned its Cincinnati, Ohio offices in July 2007. Packaged Home purported to be a 6 Case 3:10-cv-01068-O Document 1 Filed 05/27/10 Page 7 of 36 PageID 7 design and remodeling company. It formerly was quoted on the OTC Bulletin Board under the symbol “PKGH.” 25. Pet Ecology Brands, Inc. (“Pet Ecology”) is a Texas corporation with its principal place of business in Dallas, Texas. Pet Ecology purports to be a manufacturer of organic and fat-free pet products. Its stock is quoted on the Pink Sheets under the symbol “PECD.” 26. Remote Surveillance Technologies, Inc. (“Remote Surveillance”) is a Nevada corporation with its principal place of business in Irvine, California, and changed its name to Stratera, Inc. in July 2008. The company purports to deliver security systems and services. Its stock was quoted on the Pink Sheets under the symbol “RSUV” during the relevant time period. 27. Riverdale Oil and Gas Corporation, (“Riverdale”) is a Nevada corporation with its principal place of business in Austin, Texas. The company purports to own and manage a number of oil wells. Its stock is quoted on the Pink Sheets under the symbol “RVDO.” 28. Straight Up Brands, Inc. (“Straight Up”) is a Delaware corporation based in New York, New York. Straight Up purports to be a marketing firm for celebrity-branded wine and spirits. It is quoted on the Pink Sheets under the symbol “STRU.”

Share	Recommend \| Keep \| Reply \| Mark as Last Read \| Read Replies (1)

From: benignFeO2	12/20/2011 3:24:43 PM
	of 111090

CTEI .288 Transfer of CEO position from father to son: Form 8-K for CEMTREX INC 20-Dec-2011 Change in Directors or Principal Officers, Financial Statements and Exhibits Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.Effective December 19, 2011, Arun Govil, Chief Executive Officer and President of the Company resigned his positions as an officer of the Company. Mr. Govil will remain on the Board of Directors of the Company serving as its Chairman. Mr. Govil's decision to resign was not due to any dispute or disagreement with the Company on any matter relating to the Company's operations, policies or practices. A copy of Mr. Govil's resignation letter is attached as Exhibit 99.1 to this Current Report on Form 8-K. Also effective December 19, 2011, at a meeting of the Board of Directors of the Company, Saagar Govil, formerly Secretary and General Manager of Operations of the Company and a member of its Board of Directors, was appointed Chief Executive Officer of the Company. Saagar Govil, 25, has been with the Company since July 2008 as General Manager of operations. Saagar Govil has a B.S. in Materials Engineering from Stony Brooke University, N.Y. Saagar Govil is the son of Arun Govil. Item 9.01 Financial Statements and Exhibits(d) Exhibits. Exhibit No. Description 99.1 Resignation Letter of Aron Govil dated December 19, 2011

Share	Recommend \| Keep \| Reply \| Mark as Last Read

Previous 10 | Next 10

Copyright/IP Policy

Copyright © 1995-2013 Knight Sac Media. All rights reserved.